SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 18, 2003
COVALENT GROUP, INC.
(Name of Small Business Issuer in Its Charter)
Nevada | | 0-21145 | | 56-1668867 |
(State or Other Jurisdiction of Incorporation or Organization) | | (Commission file number) | | (I.R.S. Employer Identification Number) |
| | One Glenhardie Corporate Center 1275 Drummers Lane Suite 100 Wayne, Pennsylvania 19087 | | |
| | (Address of principal executive offices) | | |
| | |
| | (610) 975-9533 | | |
| | (Registrant’s telephone number, including area code) | | |
As is more fully described in the attached press release that is incorporated herein by reference, on December 18, 2003, Covalent Group, Inc. announced a strategic realignment of its senior management team.
Item 7— | | Financial Statements, Pro Forma Financial Information and Exhibits. |
(c) Exhibits
Exhibit No.
| | Description
|
| |
99.1 | | Covalent Group, Inc. Press Release December 18, 2003. |
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.
Date:December 24, 2003. | | | | Covalent Group, Inc. |
| | | | |
| | | | | | By: | | /s/ Kenneth M. Borow, M.D. |
| | | | | | |
|
| | | | | | | | Kenneth M. Borow, M.D. |
| | | | | | | | Chief Executive Officer and President |
EXHIBIT INDEX
Exhibit No.
| | Description
|
99.1 | | Covalent Group, Inc. Press Release dated December 18, 2003. |